SEC Company Response from ARTELO BIOSCIENCES, INC. (ARTL) (CIK 0001621221) (ARTL) — Nov 12, 2019
ARTELO BIOSCIENCES, INC. (ARTL) (CIK 0001621221)
Date: Nov. 12, 2019 · CIK: 0001621221 · Accession: 0001640334-19-002235
AI Filing Summary & Sentiment
File numbers found in text: 333-234372
Show Raw Text
CORRESP 1 filename1.htm corresp.htm November 12, 2019 VIA EDGAR Division of Corporation Finance U.S. Securities and Exchange Commission 100 F. Street, N.E. Attention: Daniel Morris Re: Artelo Biosciences, Inc. Registration Statement on Form S-3 Filed on October 30, 2019 File No. 333-234372 Withdrawal of Acceleration Request Dear Mr. Morris: Artelo Biosciences, Inc. (the “Company”) hereby respectfully requests withdrawal of its acceleration request filed on November 8, 2019, in which the Company requested the acceleration of the effective time and date of the Company’s Registration Statement on Form S-3 (File No. 333-234372) (the “Registration Statement”) to 4:00 p.m. Eastern time, on November 12, 2019. The Company is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date. If you have any questions regarding the foregoing, please contact our counsel, Thomas E. Hornish of Wilson Sonsini Goodrich and Rosati, Professional Corporation, at (858) 350-2392. Sincerely, ARTELO BIOSCIENCES, INC. By: /s/ Gregory D. Gorgas Name: Gregory D. Gorgas Title: President & Chief Executive Officer cc: Thomas E. Hornish, Esq. Mahnaz K. Daruwalla, Esq. Wilson Sonsini Goodrich & Rosati, Professional Corporation